Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-02-20 @ 12:33 PM
Study NCT ID:
NCT01742793
Status:
TERMINATED
Last Update Posted:
2020-03-04
First Post:
2012-11-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
Sponsor:
Organization: